<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31676570</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1469-9001</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Jan</Month></PubDate></JournalIssue><Title>RNA (New York, N.Y.)</Title><ISOAbbreviation>RNA</ISOAbbreviation></Journal><ArticleTitle>MiR-146a down-regulates inflammatory response by targeting TLR3 and TRAF6 in Coxsackievirus B infection.</ArticleTitle><Pagination><StartPage>91</StartPage><EndPage>100</EndPage><MedlinePgn>91-100</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1261/rna.071985.119</ELocationID><Abstract><AbstractText>Coxsackievirus B (CVB) is the major cause of human myocarditis and dilated cardiomyopathy. Toll-like receptor 3 (TLR3) is an intracellular sensor to detect pathogen's dsRNA. TLR3, along with TRAF6, triggers an inflammatory response through NF-&#x3ba;B signaling pathway. In the cells infected with CVB type 3 (CVB3), the abundance of miR-146a was significantly increased. The role of miR-146a in CVB infection is unclear. In this study, TLR3 and TRAF6 were identified as the targets of miR-146a. The elevated miR-146a inhibited NF-&#x3ba;B translocation and subsequently down-regulated proinflammatory cytokine expression in the CVB3-infected cells. Therefore, the NF-&#x3ba;B pathway can be doubly blocked by miR-146a through targeting of TLR3 and TRAF6. MiR-146a may be a negative regulator on inflammatory response and an intrinsic protective factor in CVB infection.</AbstractText><CopyrightInformation>&#xa9; 2020 Fei et al.; Published by Cold Spring Harbor Laboratory Press for the RNA Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fei</LastName><ForeName>Yanru</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Harbin Medical University, Harbin 150081, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaulagain</LastName><ForeName>Anita</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Harbin Medical University, Harbin 150081, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Tianying</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Harbin Medical University, Harbin 150081, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Harbin Medical University, Harbin 150081, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jinchang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Harbin Medical University, Harbin 150081, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yi</LastName><ForeName>Ming</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Harbin Medical University, Harbin 150081, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Harbin Medical University, Harbin 150081, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Yike</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harbin Medical University, Harbin 150081, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Lexun</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Harbin Medical University, Harbin 150081, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Sijia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Harbin Medical University, Harbin 150081, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Weizhen</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Harbin Medical University, Harbin 150081, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tong</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Harbin Medical University, Harbin 150081, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Xiaoyu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Cardiology, The First Hospital of Harbin Medical University, Harbin 150001, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Dechao</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cardiology, The First Hospital of Harbin Medical University, Harbin 150001, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Fengmin</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Harbin Medical University, Harbin 150081, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Wenran</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harbin Medical University, Harbin 150081, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Zhaohua</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Harbin Medical University, Harbin 150081, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>11</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>RNA</MedlineTA><NlmUniqueID>9509184</NlmUniqueID><ISSNLinking>1355-8382</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D047908">Intracellular Signaling Peptides and Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C542542">MIRN146 microRNA, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C495344">TLR3 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000604754">Tifab protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051196">Toll-Like Receptor 3</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="N">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015536" MajorTopicYN="N">Down-Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005347" MajorTopicYN="N">Fibroblasts</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D047908" MajorTopicYN="N">Intracellular Signaling Peptides and Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="N">MicroRNAs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="Y">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051196" MajorTopicYN="N">Toll-Like Receptor 3</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Coxsackievirus B</Keyword><Keyword MajorTopicYN="N">NF-&#x3ba;B</Keyword><Keyword MajorTopicYN="N">TLR3</Keyword><Keyword MajorTopicYN="N">TRAF6</Keyword><Keyword MajorTopicYN="N">miR-146a</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>5</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>10</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31676570</ArticleId><ArticleId IdType="pmc">PMC6913124</ArticleId><ArticleId IdType="doi">10.1261/rna.071985.119</ArticleId><ArticleId IdType="pii">rna.071985.119</ArticleId><ArticleId IdType="medline">9509184</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Blasius AL, Beutler B. 2010. Intracellular Toll-like receptors. Immunity 32: 305&#x2013;315. 10.1016/j.immuni.2010.03.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2010.03.012</ArticleId><ArticleId IdType="pubmed">20346772</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceppi M, Pereira PM, Dunand-Sauthier I, Barras E, Reith W, Santos MA, Pierre P. 2009. MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proc Natl Acad Sci 106: 2735&#x2013;2740. 10.1073/pnas.0811073106</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0811073106</ArticleId><ArticleId IdType="pmc">PMC2650335</ArticleId><ArticleId IdType="pubmed">19193853</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen KR, Yu CK, Kung SH, Chen SH, Chang CF, Ho TC, Lee YP, Chang HC, Huang LY, Lo SY, et al. 2018. Toll-like receptor 3 is involved in detection of enterovirus A71 infection and targeted by viral 2A protease. Viruses 10: E689 10.3390/v10120689</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v10120689</ArticleId><ArticleId IdType="pmc">PMC6315976</ArticleId><ArticleId IdType="pubmed">30563052</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukushima Y, Okamoto M, Ishikawa K, Kouwaki T, Tsukamoto H, Oshiumi H. 2018. Activation of TLR3 and its adaptor TICAM-1 increases miR-21 levels in extracellular vesicles released from human cells. Biochem Biophys Res Commun 500: 744&#x2013;750. 10.1016/j.bbrc.2018.04.146</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2018.04.146</ArticleId><ArticleId IdType="pubmed">29679565</ArticleId></ArticleIdList></Reference><Reference><Citation>Garmaroudi FS, Marchant D, Hendry R, Luo H, Yang D, Ye X, Shi J, McManus BM. 2015. Coxsackievirus B3 replication and pathogenesis. Future Microbiol 10: 629&#x2013;653. 10.2217/fmb.15.5</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb.15.5</ArticleId><ArticleId IdType="pubmed">25865198</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghose J, Sinha M, Das E, Jana NR, Bhattacharyya NP. 2011. Regulation of miR-146a by RelA/NF&#x3ba;B and p53 in STHdhQ111/HdhQ111 cells, a cell model of Huntington's disease. PLoS One 6: e23837 10.1371/journal.pone.0023837</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0023837</ArticleId><ArticleId IdType="pmc">PMC3162608</ArticleId><ArticleId IdType="pubmed">21887328</ArticleId></ArticleIdList></Reference><Reference><Citation>Gui J, Yue Y, Chen R, Xu W, Xiong S. 2012. A20 (TNFAIP3) alleviates CVB3-induced myocarditis via inhibiting NF-&#x3ba;B signaling. PLoS One 7: e46515 10.1371/journal.pone.0046515</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0046515</ArticleId><ArticleId IdType="pmc">PMC3460927</ArticleId><ArticleId IdType="pubmed">23029542</ArticleId></ArticleIdList></Reference><Reference><Citation>He X, Jing Z, Cheng G. 2014. MicroRNAs: new regulators of Toll-like receptor signaling pathways. Biomed Res Int 2014: 1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3977468</ArticleId><ArticleId IdType="pubmed">24772440</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho BC, Yu IS, Lu LF, Rudensky A, Chen HY, Tsai CW, Chang YL, Wu CT, Chang LY, Shih SR, et al. 2015. Inhibition of miR-146a prevents enterovirus-induced death by restoring the production of type I interferon. Nat Commun 5: 3344.</Citation><ArticleIdList><ArticleId IdType="pubmed">24561744</ArticleId></ArticleIdList></Reference><Reference><Citation>Janssens S, Beyaert R. 2003. Role of Toll-like receptors in pathogen recognition. Clin Microbiol Rev 16: 637&#x2013;646. 10.1128/CMR.16.4.637-646.2003</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.16.4.637-646.2003</ArticleId><ArticleId IdType="pmc">PMC207104</ArticleId><ArticleId IdType="pubmed">14557290</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang C, Zhu W, Xu J, Wang B, Hou W, Zhang R, Zhong N, Ning Q, Han Y, Yu H, et al. 2014. MicroRNA-26a negatively regulates Toll-like receptor 3 expression of rat macrophages and ameliorates pristane induced arthritis in rats. Arthritis Res Ther 16: R9 10.1186/ar4435</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar4435</ArticleId><ArticleId IdType="pmc">PMC3978458</ArticleId><ArticleId IdType="pubmed">24423102</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnnidis JB, Harris MH, Wheeler RT, Stehling-Sun S, Lam MH, Kirak O, Brummelkamp TR, Fleming MD, Camargo FD. 2008. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 451: 1125&#x2013;1129. 10.1038/nature06607</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature06607</ArticleId><ArticleId IdType="pubmed">18278031</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamali K, Korjan ES, Eftekhar E, Malekzadeh K, Soufi FG. 2016. The role of miR-146a on NF-&#x3ba;B expression level in human umbilical vein endothelial cells under hyperglycemic condition. Bratisl Med J 117: 376&#x2013;380. 10.4149/BLL_2016_074</Citation><ArticleIdList><ArticleId IdType="doi">10.4149/BLL_2016_074</ArticleId><ArticleId IdType="pubmed">27546538</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai T, Akira S. 2007. Signaling to NF-&#x3ba;B by Toll-like receptors. Trends Mol Med 13: 460&#x2013;469. 10.1016/j.molmed.2007.09.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2007.09.002</ArticleId><ArticleId IdType="pubmed">18029230</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai T, Akira S. 2011. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34: 637&#x2013;650. 10.1016/j.immuni.2011.05.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2011.05.006</ArticleId><ArticleId IdType="pubmed">21616434</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K-S, Chapman NM, Tracy S. 2008. Replication of coxsackievirus B3 in primary cell cultures generates novel viral genome deletions. J Virol 82: 2033&#x2013;2037. 10.1128/JVI.01774-07</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01774-07</ArticleId><ArticleId IdType="pmc">PMC2258713</ArticleId><ArticleId IdType="pubmed">18057248</ArticleId></ArticleIdList></Reference><Reference><Citation>Labbaye C, Testa U. 2012. The emerging role of MIR-146A in the control of hematopoiesis, immune function and cancer. J Hematol Oncol 5: 13 10.1186/1756-8722-5-13</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1756-8722-5-13</ArticleId><ArticleId IdType="pmc">PMC3342163</ArticleId><ArticleId IdType="pubmed">22453030</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H-M, Kim TS, Jo E-K. 2016. MiR-146 and miR-125 in the regulation of innate immunity and inflammation. BMB Rep 49: 311&#x2013;318. 10.5483/BMBRep.2016.49.6.056</Citation><ArticleIdList><ArticleId IdType="doi">10.5483/BMBRep.2016.49.6.056</ArticleId><ArticleId IdType="pmc">PMC5070718</ArticleId><ArticleId IdType="pubmed">26996343</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y-L, Wang J, Zhang C-Y, Shen Y-Q, Wang H-M, Ding L, Gu Y-C, Lou J-T, Zhao X-T, Ma Z-L, et al. 2016. MiR-146a-5p inhibits cell proliferation and cell cycle progression in NSCLC cell lines by targeting CCND1 and CCND2. Oncotarget 7: 59287&#x2013;59298.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5312312</ArticleId><ArticleId IdType="pubmed">27494902</ArticleId></ArticleIdList></Reference><Reference><Citation>Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2&#x2212;&#x394;&#x394;CT method. Methods 25: 402&#x2013;408. 10.1006/meth.2001.1262</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/meth.2001.1262</ArticleId><ArticleId IdType="pubmed">11846609</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchant D, Si X, Luo H, McManus B, Yang D. 2008. The impact of CVB3 infection on host cell biology. Curr Top Microbiol Immunol 323: 177&#x2013;198. 10.1007/978-3-540-75546-3_8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-540-75546-3_8</ArticleId><ArticleId IdType="pubmed">18357770</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto M, Oshiumi H, Seya T. 2011. Antiviral responses induced by the TLR3 pathway. Rev Med Virol 21: 67&#x2013;77. 10.1002/rmv.680</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.680</ArticleId><ArticleId IdType="pubmed">21312311</ArticleId></ArticleIdList></Reference><Reference><Citation>Min SK, Kim MJ, Jung SY, Kang HK, Bin JS, Min BM. 2017. MicroRNA-146a-5p limits elevated TGF-&#x3b2; signal during cell senescence. Mol Ther Nucleic Acids 7: 335&#x2013;338. 10.1016/j.omtn.2017.04.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtn.2017.04.016</ArticleId><ArticleId IdType="pmc">PMC5424570</ArticleId><ArticleId IdType="pubmed">28624209</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Neill LA, Sheedy FJ, McCoy CE. 2011. MicroRNAs: the fine-tuners of Toll-like receptor signaling. Nat Rev Immunol 268: 262&#x2013;268.</Citation><ArticleIdList><ArticleId IdType="pubmed">21331081</ArticleId></ArticleIdList></Reference><Reference><Citation>Oshiumi H, Okamoto M, Fujii K, Kawanishi T, Matsumoto M, Koike S, Seya T. 2011. The TLR3/TICAM-1 pathway is mandatory for innate immune responses to poliovirus infection. J Immunol 187: 5320&#x2013;5327. 10.4049/jimmunol.1101503</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1101503</ArticleId><ArticleId IdType="pubmed">21998457</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez De Diego R, Mulvey C, Casanova JL, Godovac-Zimmermann J. 2014. Proteomics in immunity and herpes simplex encephalitis. Expert Rev Proteomics 11: 21&#x2013;29. 10.1586/14789450.2014.864954</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14789450.2014.864954</ArticleId><ArticleId IdType="pmc">PMC4070007</ArticleId><ArticleId IdType="pubmed">24351021</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanghavi SK, Reinhart TA. 2014. Increased expression of TLR3 in lymph nodes during simian immunodeficiency virus infection: implications for inflammation and immunodeficiency. J Immunol 175: 5314&#x2013;5323. 10.4049/jimmunol.175.8.5314</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.175.8.5314</ArticleId><ArticleId IdType="pubmed">16210637</ArticleId></ArticleIdList></Reference><Reference><Citation>Sesti-Costa R, Fran&#xe7;ozo MCS, Silva GK, Proenca-Modena JL, Silva JS. 2017. TLR3 is required for survival following Coxsackievirus B3 infection by driving T lymphocyte activation and polarization: the role of dendritic cells. PLoS One 12: e0185819 10.1371/journal.pone.0185819</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0185819</ArticleId><ArticleId IdType="pmc">PMC5626506</ArticleId><ArticleId IdType="pubmed">28973047</ArticleId></ArticleIdList></Reference><Reference><Citation>Taganov KD, Boldin MP, Chang K-J, Baltimore D. 2006. NF-&#x3ba;B-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci 103: 12481&#x2013;12486. 10.1073/pnas.0605298103</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0605298103</ArticleId><ArticleId IdType="pmc">PMC1567904</ArticleId><ArticleId IdType="pubmed">16885212</ArticleId></ArticleIdList></Reference><Reference><Citation>Tatematsu M, Nishikawa F, Seya T, Matsumoto M. 2013. Toll-like receptor 3 recognizes incomplete stem structures in single-stranded viral RNA. Nat Commun 4: 1833 10.1038/ncomms2857</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms2857</ArticleId><ArticleId IdType="pubmed">23673618</ArticleId></ArticleIdList></Reference><Reference><Citation>Tili E, Michaille J-J, Cimino A, Costinean S, Dumitru CD, Adair B, Fabbri M, Alder H, Liu CG, Calin GA, et al. 2007. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-&#x3b1; stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol 179: 5082&#x2013;5089. 10.4049/jimmunol.179.8.5082</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.179.8.5082</ArticleId><ArticleId IdType="pubmed">17911593</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong L, Lin L, Zhao W, Wang B, Wu S, Liu H, Zhong X, Cui Y, Gu H, Zhang F, et al. 2011. Destabilization of coxsackievirus B3 genome integrated with enhanced green fluorescent protein gene. Intervirology 54: 268&#x2013;275. 10.1159/000321351</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000321351</ArticleId><ArticleId IdType="pubmed">21242657</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong L, Lin L, Wu S, Guo Z, Wang T, Qin Y, Wang R, Zhong X, Wu X, Wang Y, et al. 2013. MiR-10a* up-regulates coxsackievirus B3 biosynthesis by targeting the 3D-coding sequence. Nucleic Acids Res 41: 3760&#x2013;3771. 10.1093/nar/gkt058</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkt058</ArticleId><ArticleId IdType="pmc">PMC3616696</ArticleId><ArticleId IdType="pubmed">23389951</ArticleId></ArticleIdList></Reference><Reference><Citation>Trobaugh DW, Klimstra WB. 2017. MicroRNA regulation of RNA virus replication and pathogenesis. Trends Mol Med 23: 80&#x2013;93. 10.1016/j.molmed.2016.11.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2016.11.003</ArticleId><ArticleId IdType="pmc">PMC5836316</ArticleId><ArticleId IdType="pubmed">27989642</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma B, Bhattacharyya S, Das S. 2010. Polypyrimidine tract-binding protein interacts with coxsackievirus B3 RNA and influences its translation. J Gen Virol 91: 1245&#x2013;1255. 10.1099/vir.0.018507-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.018507-0</ArticleId><ArticleId IdType="pubmed">20071487</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Qin Y, Tong L, Wu S, Wang Q, Jiao Q, Guo Z, Lin L, Wang R, Zhao W, et al. 2012. MiR-342-5p suppresses coxsackievirus B3 biosynthesis by targeting the 2C-coding region. Antiviral Res 93: 270&#x2013;279. 10.1016/j.antiviral.2011.12.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2011.12.004</ArticleId><ArticleId IdType="pubmed">22197249</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M, Gao Z, Pan L, Zhang Y. 2014. Cellular microRNAs and picornaviral infections. RNA Biol 11: 808&#x2013;816. 10.4161/rna.29357</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/rna.29357</ArticleId><ArticleId IdType="pmc">PMC4179955</ArticleId><ArticleId IdType="pubmed">24921242</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X, Wu S, Tong L, Luan T, Lin L, Lu S, Zhao W, Ma Q, Liu H, Zhong Z. 2009. miR-122 affects the viability and apoptosis of hepatocellular carcinoma cells. Scand J Gastroenterol 44: 1332&#x2013;1339. 10.3109/00365520903215305</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00365520903215305</ArticleId><ArticleId IdType="pubmed">19891584</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J, Shen L, Chen J, Xu H, Mao L. 2015. The role of microRNAs in enteroviral infections. Brazilian J Infect Dis 19: 510&#x2013;516. 10.1016/j.bjid.2015.06.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bjid.2015.06.011</ArticleId><ArticleId IdType="pmc">PMC9427576</ArticleId><ArticleId IdType="pubmed">26342975</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye X, Hemida MG, Qiu Y, Hanson PJ, Zhang HM, Yang D. 2013. MiR-126 promotes coxsackievirus replication by mediating cross-talk of ERK1/2 and Wnt/&#x3b2;-catenin signal pathways. Cell Mol Life Sci 70: 4631&#x2013;4644. 10.1007/s00018-013-1411-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-013-1411-4</ArticleId><ArticleId IdType="pmc">PMC11113642</ArticleId><ArticleId IdType="pubmed">23811937</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin D, Li J, Lei X, Liu Y, Yang Z, Chen K. 2014. Antiviral activity of total flavonoid extracts from Selaginella moellendorffii hieron against coxsackie virus B3 in vitro and in vivo. Evid Based Complement Alternat Med 2014: 950817.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4055240</ArticleId><ArticleId IdType="pubmed">24963331</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Xiao Z, He F, Zou J, Wu S, Liu Z. 2013. MicroRNAs regulate the pathogenesis of CVB3-induced viral myocarditis. Intervirology 56: 104&#x2013;113. 10.1159/000343750</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000343750</ArticleId><ArticleId IdType="pubmed">23183417</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng W, Shi H, Chen Y, Xu Z, Chen J, Jin L. 2017. Alteration of serum high-mobility group protein 1 (HMGB1) levels in children with enterovirus 71-induced hand, foot, and mouth disease. Medicine (Baltimore) 96: e6764 10.1097/MD.0000000000006764</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000006764</ArticleId><ArticleId IdType="pmc">PMC5413272</ArticleId><ArticleId IdType="pubmed">28445307</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>